Related MeSH Hierarchy (4)
Diseases [C] » Neoplasms [C04] » Neoplasms by Site » Head and Neck Neoplasms » Thyroid Neoplasms
Diseases [C] » Endocrine System Diseases [C19] » Endocrine Gland Neoplasms » Thyroid Neoplasms
Diseases [C] » Endocrine System Diseases [C19] » Thyroid Diseases » Thyroid Neoplasms
Diseases [C] » Neoplasms [C04] » Neoplasms by Site » Endocrine Gland Neoplasms » Thyroid Neoplasms
Description
Tumors or cancer of the THYROID GLAND. MeSH
Hierarchy View
Subtype Terms (2)
Thyroid Cancer, Papillary
33 drugs (23 approved, 10 experimental)
Thyroid Nodule
17 drugs (15 approved, 2 experimental)
Phase 4 Indicated Drugs (17)
Phase 3 Indicated Drugs (13)
Phase 1 Indicated Drugs (46)
Other Experimental Indicated Drugs (26)
Organization Involved with Phase 3 Indications (21)
Organization Involved with Phase 2 Indications (89)
Academic and Community Cancer Research United
Case Western Reserve University
ECOG-ACRIN Cancer Research Group
European Organisation for Research and Treatment of Cancer
Icahn School of Medicine at Mount Sinai
Institut National de la Santé Et de la Recherche Médicale, France
Katholieke Universiteit Leuven
Ligue contre le cancer, France
Mashhad University of Medical Sciences
Memorial Sloan-Kettering Cancer Center
National Cancer Institute (NCI)
National Comprehensive Cancer Network
Salient Pharmaceuticals Incorporated
Shijiazhuang Pharma Group (CSPC)
Taizhou Hanzhong biomedical co. LTD
Translational Research Informatics Center, Kobe, Hyogo, Japan
Organization Involved with Phase 1 Indications (29)
INRASTES, NCSR Demokritos, Athens, Greece
James B. and Lois R. Archer Charitable Foundation
Krebsforschung Schweiz, Bern, Switzerland
NATIONAL CENTRE FOR NUCLEAR RESEARCH, Poland
Organization Involved with Other Experimental Indications (22)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
